Prognosis
Pfizer Expands Production, Adds Suppliers for Covid-19 Doses
This article is for subscribers only.
Pfizer Inc. Chief Executive Officer Albert Bourla said Friday that the company will use more of its manufacturing capacity and work with new suppliers to ramp up production of the Covid-19 vaccine it developed with BioNTech SE.
Appearing at a Pfizer plant in Michigan with President Joe Biden, Bourla said the company will employ additional capacity at its Kalamazoo site to produce the shot’s formulation as well as a component of the vaccine, known as lipids, which help deliver the genetic material into the body.